Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

IVR System Implementation and Telephone Infrastructure Support

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

517911 - Telecommunications ResellersView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Nida
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Design, implement, and maintain an Interactive Voice Response (IVR) system to route incoming calls, including automatic transfer of crisis-related calls to the 988 Suicide & Crisis Lifeline. Ensure system reliability, scalability, and integration with NIMH protocols.

Similar Contracts

Same NAICS industry code

NAICS: 517911
SLED
Telemetry and Data Transmission SystemsThe contract titled Telemetry and Data Transmission Systems involves the provision and configuration of wireless telemetry systems designed to transmit real-time sensor data from remote field units to centralized monitoring platforms. The work is scoped to ensure reliable, secure, and continuous data flow for operational monitoring, with an emphasis on system integration, calibration, and long-term performance under field conditions. The contract is structured as a subcontract under the Texas Department of Information Resources, with a solicitation window open from June 26, 2026, through June 26, 2031, allowing for extended flexibility in proposal submission and contract execution. The North American Industry Classification System code 517911 applies, indicating the focus is on other telecommunications services, particularly those involving data transmission infrastructure. While no specific geographic location is defined for performance, the agency is based in Texas, and the systems are expected to support statewide or regional monitoring applications. The contract does not specify set-aside status or point of contact details, and the primary interface for reference is the public portal hosted by Texas DIR. The nature of the work requires vendors to deliver scalable, ruggedized telemetry solutions capable of operating in diverse environmental conditions with minimal manual intervention.
Texas Department of Information Resources

POSTED

about 1 month ago

DEADLINE

in almost 5 years
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541690
New
Federal
Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV
Solicitation # 75N95026R0007
This contract solicits commercial services through a combined synopsis/solicitation under solicitation number 75N95026R0007 issued by the National Institute on Drug Abuse within the National Institutes of Health, Department of Health and Human Services. The requirement is for a firm fixed-price contract to conduct a pharmacoepidemiological study using Veterans Affairs electronic health record data to evaluate the impact of GLP-1 receptor agonists on HIV-related outcomes and alcohol and substance use disorders in adults living with HIV. The study will employ propensity-score matching and multivariable linear regression analysis to assess changes in health outcomes before and after exposure to these medications, with deliverables including aggregate-level findings, support for conference abstracts, and peer-reviewed publications led by NIDA and its collaborators. Performance is expected to occur in Bethesda, Maryland, with a base period running from August 7, 2026, to August 6, 2027, and three optional one-year extension periods through August 6, 2030. The NAICS code is 541690, with a small business size standard of $19.0 million in average annual receipts, and the acquisition is full and open with no set-aside restrictions. The solicitation requires comprehensive offer submissions including detailed technical capability demonstrations and fully loaded pricing for labor categories, hours, other direct costs, and total amounts, along with mandatory representations including UEI, TIN, and active SAM registration. Evaluation will be based on technical capability, past performance, and price, with non-price factors significantly more important than price, indicating a trade-off selection process rather than lowest price technically acceptable. Several FAR clauses are incorporated by reference, including those related to labor standards, equal opportunity, subcontracting, whistleblower rights, cybersecurity, and prohibition of confidentiality agreements that restrict reporting misconduct. Clause 52.222-49 is included in full text due to an unknown place of performance at the time of solicitation, requiring wage determinations to be retroactively applied if needed without price adjustment. Restrictions on data handling are strict: only de-identified, aggregate data may be shared outside VA systems, with no personally identifiable information permitted to leave secure VA servers. Proposals must be submitted electronically by 9:00 a.m. EST on July 30, 2026, to Robin.Knightly@nih.gov, and the contracting officer retains authority to award without further negotiation upon timely acceptance of the best
Other Scientific and Technical Consulting Services

POSTED

2 days ago

DEADLINE

in about 13 hours
View Details
NAICS: 541611
Federal
Biostatistical Modeling and Causal InferenceThe contract seeks to develop and validate statistical models aimed at evaluating causal relationships between the use of GLP-1 receptor agonists and changes in outcomes related to HIV and alcohol and other substance use disorders, utilizing observational data and advanced analytical techniques. The work requires robust methodological expertise in causal inference, including but not limited to propensity score matching, instrumental variables, and doubly robust estimation, to account for confounding in non-randomized data and produce reliable estimates of treatment effects. The project is grounded in real-world health datasets and must deliver validated models capable of informing public health understanding and policy decisions regarding metabolic and addiction-related comorbidities. The contract is classified as a subcontract under the NAICS code 541611 for scientific research and development services, and is sponsored by the National Institutes of Health through the National Institute on Drug Abuse under the Department of Health and Human Services. The performance location is specified as Bethesda, Maryland, with a response deadline of July 30, 2026, and the opportunity was posted on July 22, 2026. While no set-aside type is indicated, the work demands specialized biostatistical capabilities and a proven track record in analyzing complex longitudinal health data to support rigorous causal analysis in the context of emerging pharmacotherapies and their downstream impacts on critical public health domains.
Administrative Management and General Management Consulting Services

POSTED

7 days ago

DEADLINE

in about 13 hours
View Details
NAICS: 541611
Federal
Pharmacoepidemiological Data AnalysisThe contract requires performing advanced statistical analysis using Veterans Affairs electronic health record data to assess the effects of GLP-1 receptor agonists on outcomes related to HIV and substance use disorders. The work involves comprehensive data management, including cleaning, structuring, and validating large-scale clinical datasets, followed by the application of propensity-score matching techniques to reduce selection bias and create comparable cohorts. Regression modeling will be employed to estimate causal relationships between GLP-1 agonist exposure and key health outcomes, ensuring robustness through appropriate adjustment for confounding variables and sensitivity analyses. All analyses must adhere to strict confidentiality and compliance standards given the sensitive nature of the health data. The effort is structured as a subcontract under the National Institutes of Health, NIDA, part of the Department of Health and Human Services, with performance expected to be conducted in Bethesda, Maryland. The solicitation was posted on July 22, 2026, and responses are due by July 30, 2026, with the North American Industry Classification System code 541611 indicating it falls under scientific research and development services. While the contract does not specify a set-aside category or point of contact, the focus is squarely on delivering methodologically sound pharmacoepidemiological findings that support evidence-based policy and clinical decision-making in dual-diagnosis populations.
Administrative Management and General Management Consulting Services

POSTED

7 days ago

DEADLINE

in about 13 hours
View Details
NAICS: 541990
Federal
Notice of Ordering Period Extension-Clinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet
Solicitation # 75N95024D00002
The National Institute on Aging intends to extend the ordering period of its existing IDIQ contract with the University of Exeter, UK, by one year, moving the deadline from August 1, 2026, to August 1, 2027, to ensure completion of planned clinical work under Task Orders 2 and 3. This contract supports the clinical evaluation of (-)-Phenserine tartrate Extended Controlled Release Tablet (ECRT) in two patient populations: individuals with early mild Alzheimer’s disease and those with mild to moderate traumatic brain injury. The study involves phase 1/2 clinical trials to assess pharmacokinetic and pharmacodynamic profiles, including steady-state drug concentrations, target engagement, tolerability, and biomarker outcomes through blood sampling, cognitive testing, and brain imaging. The contractor will deliver all necessary personnel, facilities, and resources to administer the drug under rigorously controlled conditions, with the government providing the drug substance, including an immediate-release formulation if needed to achieve target plasma levels. The work is non-competitive, authorized under 41 U.S.C. 3304(a)(1) and aligned with RFO Subpart 6.103-1, as the University of Exeter is the only responsible source capable of delivering the required expertise. The contract is classified under NAICS code 541990 with a $19.5 million size standard, and no follow-on procurements are anticipated. All responses to this presolicitation notice must be submitted electronically by July 30, 2026, to the designated contracting officer, and require an active SAM registration, UEI, TIN, and business size certification.
All Other Professional, Scientific, and Technical Services

POSTED

14 days ago

DEADLINE

in about 21 hours
View Details